NASDAQ: VRTX · Biotechnology
Over the past week, Vertex Pharmaceuticals (VRTX) drew about 27 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 68% bullish but is far apart: Reddit runs 100% bullish while News sits at just 41%. Wall Street is more constructive, with 26 of 32 analysts rating VRTX a buy.
There is little buzz around VRTX this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 81% buy share sits next to a crowd that ranges from News at 41% to Reddit at 100%. No other tracker puts the two side by side.
Across 32 analysts the consensus is a Strong Buy: 26 buy calls against 2 sell, with an average 12-month price target of $571.61.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Buy.
Analysts sit 13 points above the crowd average of 68%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 100% bullish while News sits at 41%, a 59-point spread that single-source trackers miss.
Over the 30-day window, Vertex Pharmaceuticals (VRTX) buzz held moderate around 47.3 while the price drifted down 1.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1M shares. Updated Oct 10, 2026. Over the last 7 trading days, VRTX gained 0.7%. Buzz activity in the recent week averaged 36.7 and was variable, swinging between 26.2 and 47.3. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 20 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for VRTX and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live VRTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (26 / 4 / 2) |
| Crowd bullish (7d) | 68% |
| Avg price target | $571.61 |
| Most bullish source | Reddit, 100% |
| Most bearish source | News, 41% |
| Sentiment spread | 59 pts |
| Mentions (7d) | 27 |
| Market cap | $127.55B |
| P/E · Forward P/E | 29.3 · 24.1 |
| EPS · Beta | $17.17 · 0.3 |
| Revenue (TTM) | $12.59B · 35% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Vertex Pharmaceuticals (VRTX) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 68% bullish across 3 active sources. Those sources contribute 27 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Vertex Pharmaceuticals (VRTX) is fairly quiet with 2 mentions over the last 7 days; the 30-day context spans 6 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Vertex Pharmaceuticals (VRTX), averaging 68% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 100% bullish and News at 41%, a 59-point spread. On the professional side, 26 of 32 analysts rate VRTX a buy.
Of the 32 analysts covering Vertex Pharmaceuticals (VRTX), 26 rate it a buy, 4 a hold and 2 a sell, for a strong buy consensus. The average price target is $571.61. That puts the street ahead of the crowd, which averages 68% bullish.
Vertex Pharmaceuticals (VRTX)'s cross-source average is bullish at 68% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. Reddit reads 100% bullish, X reads 63% bullish and news coverage is the most negative at 41% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Vertex Pharmaceuticals (VRTX) at 68% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is news at 41% bullish. 3-day activity momentum is falling across X. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 17 mentions (63% of total volume). X contributes 8 mentions and Reddit contributes 2 mentions. The cross-source average is bullish at 68% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. VRTX's buy signal at 93/100 conviction reflects a bullish cross-source average at 68% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The VRTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key